Grants Awarded

Use of a Response-Adapted Ruxolitinib-Containing Regimen for the Treatment of Hemophagocytic Lymphohistiocytosis

December 16, 2019 |

Melissa Hines
St Jude Children’s Research Hospital, Memphis, TN USA

Back to All Grants